Zika cases detected in Woodlands: What you need to know about the virus
The National Environment Agency (NEA) said enhanced surveillance has revealed persistent Zika virus signals in the area, which suggest it is an area with likely Zika transmission. The Zika virus has been found in wastewater or mosquito samples collected in the vicinity of the reported cases.
A check on the NEA website shows that as at June 18, there are no Zika clusters in Singapore.
Here's what you need to know about the virus:
Zika is a viral infection spread mainly through the bite of an infected Aedes species mosquito, which also carries the dengue and chikungunya viruses.
It can be transmitted through sex, transfusion of blood and blood products, or from mother to foetus during pregnancy. There is no noticeable pattern as to when Zika cases tend to peak.
The symptoms of Zika and dengue are similar. The viruses can be differentiated by virological tests.
Only one in five people infected with the virus displays symptoms. The most common symptoms are fever, rash, headache, joint and muscle pain, and red eyes.
The symptoms usually develop between three and 12 days after the mosquito bite and often lasts between four and seven days. Nausea and vomiting may also occur. Individuals who suspect they have contracted Zika should see a doctor quickly, advised NEA.
A reverse transcriptase-polymerase chain reaction (RT-PCR) test uses blood and urine tests to determine the infection. Zika infection in blood can be detected between five and seven days of the onset of symptoms, and in urine within 14 days of the first appearance of symptoms.
Unborn babies are at greatest risk should their mother get infected with the Zika virus.
Between 1 per cent and 10 per cent of women infected during pregnancy give birth to babies with birth defects.
The most common defect is microcephaly where the baby is born with a much smaller head and often a smaller brain that might not have developed properly. Other birth defects include difficulty swallowing, hearing loss, and vision problems and seizures.
Not all babies born with congenital Zika virus will have all of these conditions. Some babies develop long-term health problems later on in their life.
There is no known cure for the Zika virus, but symptoms of the infection can be treated.
To avoid getting infected, people are advised to use mosquito repellant and wear clothing that covers the body, arms and legs.
NEA also advises the public to prevent mosquito breeding by removing stagnant water at home and surrounding areas. Stagnant water in potted plants should also be emptied regularly. Sleeping under mosquito nets and in rooms with wire-mesh screens can also help keep out mosquitoes.
According to the World Health Organisation (WHO), the first notable outbreak of the virus was in 1952. It was first identified in monkeys in Uganda in 1947. WHO declared the virus a public health emergency in 2016. The first imported case of the virus in Singapore was in May 2016. The first local cluster was detected in August 2016 in the Aljunied area, with a total of 298 cases. The outbreak was contained in four weeks.
According to NEA's website, about 72,000 gravitraps are currently deployed across Singapore.
There have been a total of seven laboratory-confirmed Zika cases in Singapore as at June 12, 2025. There were 13 recorded cases in 2024.
There is currently no evidence that suggests pregnant women are more vulnerable to the Zika virus. However, the effects of the infection are more severe should a pregnant woman contract it.
The unborn child can develop a range of birth defects such as microcephaly and other issues later in life.
Zika-associated birth defects are more common in infants born to women with exposure to the virus early in the pregnancy.
The highest risk of Zika-associated birth defects is with infections that occur during the first and second trimesters of the pregnancy.
If a non-pregnant woman contracts the virus, future pregnancies are unlikely to be at risk.
The RT-PCR test, which looks for genetic material of the virus in blood or urine, can be used to determine if a pregnant woman is infected.
If a pregnant woman is tested positive or inconclusive for Zika, she will be referred to a maternal foetal medicine specialist for counselling and management. She will be closely monitored and offered regular foetal ultrasounds. The healthcare professional may suggest amniotic fluid testing.
She should take strict precautions against mosquito bites. There is no need to see a doctor if she is well. If she has symptoms of a possible Zika virus infection, she should seek medical attention immediately and consult an obstetrics and gynaecology doctor.
SOURCES: World Health Organisation, National Environment Agency, Communicable Diseases Agency Singapore, US Centre for Disease Control and Prevention, European Centre for Disease Prevention and Control
Source: The Straits Times © SPH Media Limited. Permission required for reproduction
Discover how to enjoy other premium articles here

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Starmer thanks NHS worker who looked after his brother
The Prime Minister has thanked an NHS worker who looked after his brother in the last weeks of his life. Sir Keir Starmer's brother Nick died on Boxing Day in 2024 aged 60, having been ill with cancer. In a video posted on social media to mark the 77th anniversary of the health service, the PM said that advanced nurse practitioner Ben Huntley made sure that his brother 'felt cared for and respected'. In the clip, Sir Keir is shown speaking to Mr Huntley in Downing Street, while other members of the public also meet with NHS staff who helped them. The NHS has always been there for my family. Today, on its 77th anniversary, the entire country says thank you. — Keir Starmer (@Keir_Starmer) July 5, 2025 The Prime Minister said: 'My mum worked in the NHS and then she was very, very ill, for most of her life. And the NHS became our absolute lifeline. 'My sister worked for the NHS, my wife works for the NHS, and it was the NHS that looked after my brother who we lost last Boxing Day to cancer. 'Ben, you looked after him. I think from the moment he was in all the way through, and you made sure that he felt cared for and respected.' The PM later added: 'That meant a huge amount to me and my family and, on all of our behalves, I say through you a very special thank you to the NHS.' Earlier this week, Sir Keir told the BBC's Political Thinking that he 'made it my business to be there in the hospital' when his brother was told about his diagnosis 'so that I could begin to help look after him'. 'It's really hard to lose your brother to cancer, he was a very vulnerable man,' the Prime Minister said. He shared details of 'going up in the porter's lift into the back of the intensive care unit' and wanting to protect his brother's privacy. He told the same interview that US President Donald Trump asked about his brother in a call a 'few days' after he died.
Yahoo
an hour ago
- Yahoo
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott's future dual glucose-ketone sensor in the US. The collaboration aims to enhance real-time decision-making support for individuals with diabetes. The iLet Bionic Pancreas received FDA clearance in May 2023 and is distinguished as the first and only AID system that autonomously makes 100% of insulin dosing decisions. This eliminates the need for carb counting or manual insulin correction calculations for users, though they still need to be 'carb aware.' The system currently supports Abbott's FreeStyle Libre 3 Plus continuous glucose monitoring sensor, and the new agreement deepens the ongoing partnership between Beta Bionics and Abbott. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The new dual sensor is currently under development and is built on the same form factor as Abbott's FreeStyle Libre 3 Plus and will continuously monitor both glucose and ketone levels. Ketone monitoring is a crucial advancement as it can help detect early signs of diabetic ketoacidosis, which is a serious complication of diabetes. Abbott's dual glucose-ketone sensor has received FDA breakthrough device designation. Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells health care products. Beta Bionics Inc. (NASDAQ:BBNX) is a commercial-stage medical device company. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies
BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best new stocks to buy now. On June 18, BrightSpring Health Services announced that its specialty pharmacy, called Onco360, has been chosen as the national pharmacy partner for several newly approved therapies. These innovative treatments target advanced cancers and rare genetic disorders. BrightSpring delivers care and clinical solutions to 400,000+ customers, clients, and patients daily across all 50 states. Onco360 will provide access, education, data, and expert support for patients suffering from advanced ovarian and lung cancers, as well as neurofibromatosis type 1. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. Onco360 has been selected as a pharmacy partner for the following specific medication therapies: GOMEKLI, which is approved for adult and pediatric patients aged 2 years and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas/PN not suitable for complete resection; AVMAPKI FAKZYNJA CO-PACK, which is approved for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer/LGSOC who have received prior systemic therapy; and IBTROZI, which is approved for adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US that operates through 2 segments: Pharmacy Solutions and Provider Services. Onco360 is a national, independent Oncology Pharmacy and clinical support services company. While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data